Transarterial chemoembolization combined with apatinib with or without PD-1 inhibitors in BCLC stage C hepatocellular carcinoma: A multicenter retrospective study
Wei-Li Xia(Zhengzhou University), Hai-Liang Li(Zhengzhou University), Yuan Guo(University of Leeds), Gang Wu(First Affiliated Hospital of Zhengzhou University), Weijun Fan(Sun Yat-sen University), Quan-Jun Yao(Zhengzhou University), Chenyang Guo(Zhengzhou University), Shi‐Jun Xu(Chengdu University of Traditional Chinese Medicine), Xiaohui Zhao(Army Medical University), Hongtao Hu(Wuhan University), Guangshao Cao(Henan University)
Cited by 25
Related Papers
Structural basis for distinct ligand-binding and targeting properties of the receptors DC-SIGN and DC-SIGNR
|Nature Structural & Molecular Biology|2004|607
Microalgal-bacterial consortia: From interspecies interactions to biotechnological applications
|Renewable and Sustainable Energy Reviews|2019|440
Transarterial chemoembolization with PD-(L)1 inhibitors plus molecular targeted therapies for hepatocellular carcinoma (CHANCE001)
|Signal Transduction and Targeted Therapy|2023|295
Enhancement of aerobic granulation and nutrient removal by an algal–bacterial consortium in a lab-scale photobioreactor
|Chemical Engineering Journal|2017|289